November 16, 2020

Coffee & Conversation - Building an Effective Compliance Program: Key Considerations for the Pharmaceutical Industry

In this episode of Coffee & Conversation, Elissa McClure and Sydne Collier chat with Virginia Fitt, the head of commercial law and compliance at biopharmaceutical company ChemoCentryx. They talk about key compliance takeaways from recent settlements in the pharmaceutical industry, including the importance of "careful communications" and related protocols. Ms. Fitt also shares her approach to ensuring transparency around policies and guidelines, getting executive buy-in for compliance programs and using data to refine those programs. The conversation concludes with Virginia's insights into what makes for good outside counsel and what law firms can do to meet companies' expectations in this area.

 

Insights relacionados